{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"59.0","upperLimit":"91.7","value":"78.6"},{"groupId":"OG001","lowerLimit":"69.8","upperLimit":"97.6","value":"88.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"26"}],"units":"Participants"}],"description":"Complete Response is defined as 3 consecutive bi-weekly values of hCG\\<5 over a minimum of 4 weeks of normal hCG values with no values greater than 5 mIU/ml","dispersionType":"95% Confidence Interval","groups":[{"description":"IV pulse actinomycin-D (1.25mg/m2 ) every 14 days. (2mg max dose)","id":"OG000","title":"Regimen I (Dactinomycin)"},{"description":"institutional preference of either:\n\n* IV methotrexate (0.4 mg/kg) daily for 5 days every 14 days. (25mg max daily dose) OR\n* IM methotrexate (50mg) on Days 1, 3, 5, 7 (4 doses per cycle) with Leucovorin (15mg) on Days 2, 4, 6, 8. Repeat every 14 days.","id":"OG001","title":"Regimen II (Methotrexate)"}],"paramType":"NUMBER","populationDescription":"Eligible patients","reportingStatus":"POSTED","timeFrame":"hCG testing is performed prior to each cycle to treatment until treatment is completed, up to 10 months. For patients who have responded to treatment hCG must be obtained every 4 weeks for 1 year after completing treatment.","title":"Percentage of Participants With Complete Response","type":"PRIMARY","unitOfMeasure":"percentage of participants"}